World News
Swipe up for the next story
A handout video grab image shows the production process of Shionogi & Co Ltd's ongoing clinical trial of pills, known as S-217622, for the oral coronavirus disease (COVID-19) treatment.

Japanese drug maker says Covid-19 pill shows rapid clearance of virus

An experimental treatment from Shionogi & Co Ltd has shown rapid clearance of the virus that causes COVID-19, according to new data, the Japanese drug maker said on Sunday. The pill, S-217622, "demonstrated rapid clearance of the infectious SARS-CoV-2 virus", Shionogi said in a statement, citing Phase-2b results from the Phase II/III clinical trial of the drug. Shionogi's shares have been on a rollercoaster on speculation about success of the treatment.

Story Saved
Saved Articles
My Reads
My Offers
Sign out
New Delhi 0C
Tuesday, February 07, 2023
Start 15 Days Free Trial Subscribe Now
Register Free and get Exciting Deals